Evidence map›Paper›PMID 31078080›Full record

ArticleForensic science international2019

Evaluation of a lateral flow immunoassay for the detection of the synthetic opioid fentanyl.

Daniel J Angelini, Tracey D Biggs, Michele N Maughan, Michael G Feasel, Edward Sisco, Jennifer W Sekowski

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Forensic science international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Interpol Review of Drug Analysis 2019-2022.Forensic science international. Synergy · 2023
    Review
  10. Article
  11. Review
  12. Thermally Responsive Alkane Partitions for Assay Automation.ACS applied materials & interfaces · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daniel J AngeliniU.S. Army, Combat Capabilities Development Command Chemical Biological Center, Aberdeen Proving Ground, MD, USA. Electronic address: daniel.j.angelini2.civ@mail.mil.
Tracey D BiggsU.S. Army, Combat Capabilities Development Command Chemical Biological Center, Aberdeen Proving Ground, MD, USA.
Michele N MaughanExcet, Inc., Springfield, VA, USA.
Michael G FeaselU.S. Army, Combat Capabilities Development Command Chemical Biological Center, Aberdeen Proving Ground, MD, USA.
Edward SiscoNational Institute of Standards & Technology, Materials Measurement Science Division, Gaithersburg, MD, USA.
Jennifer W SekowskiU.S. Army, Combat Capabilities Development Command Chemical Biological Center, Aberdeen Proving Ground, MD, USA.
United States Army Combat Capabilities Development Command · USExcet (United States) · USNational Institute of Standards and Technology · US

Funding

Intramural NIST DOC 9999-NIST
6 · The paper itself

Abstract

In 2017, 47,600 overdose deaths were reported to be associated with the abuse of opioids, including prescription painkillers (e.g. oxycodone), opiates (e.g. heroin), or synthetic opioids (e.g. fentanyl) within the United States. The recent spike in the presence of synthetic opioids in lots of heroin distributed on the street present specific and significant challenges to law enforcement. Synthetic opioids are extremely toxic substances, which can easily be inhaled. This type of exposure can lead to accidental overdoses by law enforcement and other first responders answering calls involving illicit drugs containing these substances. Due to this extreme toxicity, it is important for these individuals to have tools that can be easily deployed for accurate presumptive field tests. Currently, there are only a limited number of presumptive tests available for fentanyl detection. In this study, we addressed this technology gap by evaluating newly developed lateral flow immunoassays (LFIs) designed for the detection of fentanyl and its derivatives. These LFIs were evaluated for effectiveness in different biofluid matrices, following an in vivo exposure, cross-reactivity with fentanyl analogs, and in case samples. This study demonstrates that LFIs have the potential to be used by law enforcement for the detection of synthetic opioids.

Indexed as

Analgesics, OpioidAnimalsFentanylHumansIllicit DrugsImmunoassayLimit of DetectionOpioid-Related DisordersRabbitsSalivaSubstance Abuse DetectionAnalgesics, OpioidFentanylIllicit DrugsDetectionFentanylForensic scienceIllicit drugLateral flow immunoassayOpioid

Identifiers

PMID31078080
PMCPMC6956851
OpenAlexW2941490043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.